Studies on HepG2 growth under simulated microgravity: To establish a method for three-dimensional cultivation in vitro as an research model

Progress in Biochemistry and Biophysics

Volumn 34, Issue 2, 2007, Pages 146-153

  Xu, Da Yong ^a   Yun, Wang ^a   Feng, Mei Fu ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

Cell adhesion molecules (CAMs); HepG2; Polyglycolic acid (PGA); Rotating cell culture system (RCCS); Simulated microgravity; Three dimensional culture

Indexed keywords

EID: 34248517485     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Obayashi H K, Man S, Graham C H, et al. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci USA, 1993, 90 (8): 3294-3298
2. Birgersdotter A, Sandberg R, Ernberg I. Gene expression perturbation in vitro: a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol, 2005, 15 (5): 405-412
3. Nishikawa M, Ohgushi H, Tamai N, et al. The effect of simulated microgravity by three-dimensional clinostat on bone tissue engineering. Cell Transplant, 2005, 14 (10): 829-835
4. Michelini M, Franceschini V, Sihui Chen S, et al. Primate embryonic stem cells create their own niche while differentiating in three-dimensional culture systems. Cell Prolif, 2006, 39 (3): 217-229
5. Abilez O, Benharash P, Mehrotra M, et al. A novel culture system shows that stem cells can be grown in 3D and under physiologic pulsatile conditions for tissue engineering of vascular grafts. J Surg Res, 2006, 132 (2): 170-178
6. Grayson WL, Ma T, Bunnell B. Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol Prog, 2004, 20 (3): 905-912
7. Moiseeva E P, Fox L H, Howells L M, et al. Indole-3-carbinol- induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment. Apoptosis, 2006, 11 (5): 799-812
8. Wang R, Xu J, Juliette L, et al. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone. Semin Cancer Biol, 2005, 15 (5): 353-364
9. Lorenzo R, Renzo C. Retinole acid modulates the radiosensitivity of head-and-neck squamous carcinoma cells grown in collagen gel. Int J Radiat Oncol Biol Phys, 2002, 53 (5): 1319-1327
10. Barnea A, Cho G, Lu G, et al. Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y-producing neurons. J Neurosci Res, 1995, 42 (5): 638-647
11. Levenberg S, Huang N F, Lavik E, et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA, 2003, 100 (22): 12741-127460PM
12. Schwarz R P, Goodwin T J, Wolf D A. Cell culture for three-dimensional modeling in rotating-wall vessels: an application of stimulated microgravity. J Tiss Cult Meth, 1992, 14 (2): 51-58
13. Graham C H, Kobayashi H, Stankiewicz K S, et al. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst, 1994, 86 (13): 975-982
14. Sutherland R M. Importance of critical metabolites and cellular interactions in the biology of microregions of tumors. Cancer, 1986, 58 (8):1668-1680
15. Bauer K D, Keng P C, Sutherland R M. Isolation of quiescent cells from multicellular tumor spheroids using centrifugal elutriation. Cancer Res, 1982, 42 (1): 72-78
16. Luk C K, Sutherland R M. Nutrient modification of proliferation and radiation response in EMT6/Rospheroids. Int J Radiat Oncol Boil Phys, 1987, 13 (6): 885-895
17. Tannock I F, Kopelyan I. Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line. Cancer Res, 1986, 46 (6): 3105-3110
18. Furbert-Harris P M, Parish-Gause D, Hunter K A, et al. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells. Cell Mol Biol (Noisy-le-grand), 2003, 49 (7): 1009-1016
19. Cohen M B, Griebling T L, Ahaghotu C A, et al. Cellular adhesion molecules in urologie malignancies. Am J Clin Pathol, 1997, 107 (1): 56-63
20. Wimmenauer S, Keller H, Ruckauer K D, et al. Expression of CD44, ICAM-I and N-CAM in colorectal cancer. Correlation with the tumor stage and the phenotypical characteristics of tumor-infiltrating lymphocytes. Anticancer Res, 1997, 17 (4A): 2395-2400
21. Zhang Z, Vuori K, Reed J C, et al. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA, 1995, 92 (13): 6161-6165
22. Kantak S S, Kramer R H. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem, 1998, 273 (27): 16953-16961
23. Torimura T, Ueno T, Kin M, et al. Integrin alpha 6 betai 1 plays a significant role in the attachment of hepatoma cells to laminin. J Hepatol, 1999, 31: 734-740
24. Paroli M, Carloni G, Franco A, et al. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-l/ICAM-1 interaction. Immunol, 1994, 82 (2): 215-221
25. Masumoto A, Arao S, Otsuki M. Role of betal integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology, 1999, 29 (1): 68-74
26. Momosaki S, Yano H, Ogasawara S, et al. Expression of intercellular adhesion molecule-1 in human hepatocellular carcinoma. Hepatol, 1995, 22 (6): 1708-1713
27. Hyodo I, Jinno K, Tanimizu M, et al. Intercellular adhesion molecule-1 release from human hepatocellular carcinoma. Cancer Detect Prev, 1996, 20 (4): 308-315
28. Soresi M, Cervello M, Lipani G, et al. Circulating intercellular adhesion molecule- 1 in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 1997, 9 (8): 805-809
29. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci, 1999, 24 (2): 73-76
30. Slagle B L, Zhou Y Z, Birchmeier W, et al. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology, 1993, 18 (4): 757-762
31. Desoize B, Jardillier J. Multicellular resistance: a paradigm for clinical resistance. Crit Rev Oncol Hematol, 2000, 36 (2-3): 193-207